Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 52 entries
Sorted by: Best Match Show Resources per page
A National Long-term Outcomes Evaluation of U.S. Premedical Postbaccalaureate Programs Designed to Promote Health care Access and Workforce Diversity.

Journal of health care for the poor and underserved

McDougle L, Way DP, Lee WK, Morfin JA, Mavis BE, Matthews D, Latham-Sadler BA, Clinchot DM.
PMID: 26320900
J Health Care Poor Underserved. 2015 Aug;26(3):631-47. doi: 10.1353/hpu.2015.0088.

UNLABELLED: The National Postbaccalaureate Collaborative (NPBC) is a partnership of Postbaccalaureate Programs (PBPs) dedicated to helping promising college graduates from disadvantaged and underrepresented backgrounds get into and succeed in medical school. This study aims to determine long-term program outcomes...

Cite
McDougle L, Way DP, Lee WK, et al. A National Long-term Outcomes Evaluation of U.S. Premedical Postbaccalaureate Programs Designed to Promote Health care Access and Workforce Diversity. J Health Care Poor Underserved. 2015;26(3):631-47doi: 10.1353/hpu.2015.0088.
McDougle, L., Way, D. P., Lee, W. K., Morfin, J. A., Mavis, B. E., Matthews, D., Latham-Sadler, B. A., & Clinchot, D. M. (2015). A National Long-term Outcomes Evaluation of U.S. Premedical Postbaccalaureate Programs Designed to Promote Health care Access and Workforce Diversity. Journal of health care for the poor and underserved, 26(3), 631-47. https://doi.org/10.1353/hpu.2015.0088
McDougle, Leon, et al. "A National Long-term Outcomes Evaluation of U.S. Premedical Postbaccalaureate Programs Designed to Promote Health care Access and Workforce Diversity." Journal of health care for the poor and underserved vol. 26,3 (2015): 631-47. doi: https://doi.org/10.1353/hpu.2015.0088
McDougle L, Way DP, Lee WK, Morfin JA, Mavis BE, Matthews D, Latham-Sadler BA, Clinchot DM. A National Long-term Outcomes Evaluation of U.S. Premedical Postbaccalaureate Programs Designed to Promote Health care Access and Workforce Diversity. J Health Care Poor Underserved. 2015 Aug;26(3):631-47. doi: 10.1353/hpu.2015.0088. PMID: 26320900; PMCID: PMC4765949.
Copy Download .nbib Format: NLM
Development Of An Educational Video To Improve Patient Knowledge And Communication With Their Healthcare Providers About Colorectal Cancer Screening.

American journal of health education

Katz ML, Heaner S, Reiter P, van Putten J, Murray L, McDougle L, Cegala DJ, Post D, David P, Slater M, Paskett ED.
PMID: 20209024
Am J Health Educ. 2009 Jul;40(4):220-228. doi: 10.1901/jaba.2009.40-220.

BACKGROUND: Low rates of colorectal cancer (CRC) screening persist due to individual, provider and system level barriers. PURPOSE: To develop and obtain initial feedback about a CRC screening educational video from community members and medical professionals. METHODS: Focus groups...

Cite
Katz ML, Heaner S, Reiter P, et al. Development Of An Educational Video To Improve Patient Knowledge And Communication With Their Healthcare Providers About Colorectal Cancer Screening. Am J Health Educ. 2009;40(4):220-228doi: 10.1901/jaba.2009.40-220.
Katz, M. L., Heaner, S., Reiter, P., van Putten, J., Murray, L., McDougle, L., Cegala, D. J., Post, D., David, P., Slater, M., & Paskett, E. D. (2009). Development Of An Educational Video To Improve Patient Knowledge And Communication With Their Healthcare Providers About Colorectal Cancer Screening. American journal of health education, 40(4), 220-228. https://doi.org/10.1901/jaba.2009.40-220
Katz, Mira L, et al. "Development Of An Educational Video To Improve Patient Knowledge And Communication With Their Healthcare Providers About Colorectal Cancer Screening." American journal of health education vol. 40,4 (2009): 220-228. doi: https://doi.org/10.1901/jaba.2009.40-220
Katz ML, Heaner S, Reiter P, van Putten J, Murray L, McDougle L, Cegala DJ, Post D, David P, Slater M, Paskett ED. Development Of An Educational Video To Improve Patient Knowledge And Communication With Their Healthcare Providers About Colorectal Cancer Screening. Am J Health Educ. 2009 Jul;40(4):220-228. doi: 10.1901/jaba.2009.40-220. PMID: 20209024; PMCID: PMC2832292.
Copy Download .nbib Format: NLM
Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders.

Current treatment options in neurology

Wink LK, Erickson CA, McDougle CJ.
PMID: 20848330
Curr Treat Options Neurol. 2010 Nov;12(6):529-38. doi: 10.1007/s11940-010-0091-8.

OPINION STATEMENT: Pervasive developmental disorders (PDDs), including autistic disorder (autism), Asperger's disorder, and pervasive developmental disorder not otherwise specified (PDD NOS), are neurodevelopmental disorders of childhood onset. These disorders persist throughout the lifespan of affected individuals and are characterized...

Cite
Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Curr Treat Options Neurol. 2010;12(6):529-38doi: 10.1007/s11940-010-0091-8.
Wink, L. K., Erickson, C. A., & McDougle, C. J. (2010). Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current treatment options in neurology, 12(6), 529-38. https://doi.org/10.1007/s11940-010-0091-8
Wink, Logan K, et al. "Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders." Current treatment options in neurology vol. 12,6 (2010): 529-38. doi: https://doi.org/10.1007/s11940-010-0091-8
Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Curr Treat Options Neurol. 2010 Nov;12(6):529-38. doi: 10.1007/s11940-010-0091-8. PMID: 20848330.
Copy Download .nbib Format: NLM
Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Neuropsychiatric disease and treatment

Walsh KH, McDougle CJ.
PMID: 21931490
Neuropsychiatr Dis Treat. 2011;7:485-94. doi: 10.2147/NDT.S13205. Epub 2011 Aug 23.

Obsessive-compulsive disorder (OCD) is a chronic anxiety disorder. While medication and psychotherapy advances have been very helpful to patients, many patients do not respond adequately to initial trials of serotonergic medication or cognitive-behavioral therapy (CBT) and require multiple treatment...

Cite
Walsh KH, McDougle CJ. Psychotherapy and medication management strategies for obsessive-compulsive disorder. Neuropsychiatr Dis Treat. 2011;7:485-94doi: 10.2147/NDT.S13205.
Walsh, K. H., & McDougle, C. J. (2011). Psychotherapy and medication management strategies for obsessive-compulsive disorder. Neuropsychiatric disease and treatment, 7485-94. https://doi.org/10.2147/NDT.S13205
Walsh, Kelda H, and McDougle, Christopher J. "Psychotherapy and medication management strategies for obsessive-compulsive disorder." Neuropsychiatric disease and treatment vol. 7 (2011): 485-94. doi: https://doi.org/10.2147/NDT.S13205
Walsh KH, McDougle CJ. Psychotherapy and medication management strategies for obsessive-compulsive disorder. Neuropsychiatr Dis Treat. 2011;7:485-94. doi: 10.2147/NDT.S13205. Epub 2011 Aug 23. PMID: 21931490; PMCID: PMC3173031.
Copy Download .nbib Format: NLM
Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Pediatric health

Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ.
PMID: 21359119
Ped Health. 2010 Sep 29;4(4):375-381. doi: 10.2217/phe.10.45.

Aripiprazole was recently US FDA-approved to treat irritability in children and adolescents with autistic disorder aged 6-17 years. There are currently only two psychotropics approved by the FDA to treat irritability in the autistic population. This drug profile will...

Cite
Blankenship K, Erickson CA, Stigler KA, et al. Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. Ped Health. 2010;4(4):375-381doi: 10.2217/phe.10.45.
Blankenship, K., Erickson, C. A., Stigler, K. A., Posey, D. J., & McDougle, C. J. (2010). Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. Pediatric health, 4(4), 375-381. https://doi.org/10.2217/phe.10.45
Blankenship, Kelly, et al. "Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years." Pediatric health vol. 4,4 (2010): 375-381. doi: https://doi.org/10.2217/phe.10.45
Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ. Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. Ped Health. 2010 Sep 29;4(4):375-381. doi: 10.2217/phe.10.45. PMID: 21359119; PMCID: PMC3043611.
Copy Download .nbib Format: NLM
Family Sense-Making After a Down Syndrome Diagnosis.

Qualitative health research

Clark L, Canary HE, McDougle K, Perkins R, Tadesse R, Holton AE.
PMID: 32618226
Qual Health Res. 2020 Oct;30(12):1783-1797. doi: 10.1177/1049732320935836. Epub 2020 Jul 03.

The script of parenting shifts when parents learn of their child's Down syndrome diagnosis. To build a theory of the diagnostic experience and early family sense-making process, we interviewed 33 parents and nine grandparents living in the United States...

Cite
Clark L, Canary HE, McDougle K, et al. Family Sense-Making After a Down Syndrome Diagnosis. Qual Health Res. 2020;30(12):1783-1797doi: 10.1177/1049732320935836.
Clark, L., Canary, H. E., McDougle, K., Perkins, R., Tadesse, R., & Holton, A. E. (2020). Family Sense-Making After a Down Syndrome Diagnosis. Qualitative health research, 30(12), 1783-1797. https://doi.org/10.1177/1049732320935836
Clark, Lauren, et al. "Family Sense-Making After a Down Syndrome Diagnosis." Qualitative health research vol. 30,12 (2020): 1783-1797. doi: https://doi.org/10.1177/1049732320935836
Clark L, Canary HE, McDougle K, Perkins R, Tadesse R, Holton AE. Family Sense-Making After a Down Syndrome Diagnosis. Qual Health Res. 2020 Oct;30(12):1783-1797. doi: 10.1177/1049732320935836. Epub 2020 Jul 03. PMID: 32618226; PMCID: PMC7814853.
Copy Download .nbib Format: NLM
Post-error Slowing During Instrumental Learning is Shaped by Working Memory-based Choice Strategies.

Neuroscience

McDougle SD.
PMID: 34695537
Neuroscience. 2021 Oct 23; doi: 10.1016/j.neuroscience.2021.10.016. Epub 2021 Oct 23.

Post-error slowing (PES) - a relative increase in response time for a decision on trialtgiven an error on trialt - 1 - is a well-known effect in studies of human decision-making. Post-error processing is reflected in neural signatures such...

Cite
McDougle SD. Post-error Slowing During Instrumental Learning is Shaped by Working Memory-based Choice Strategies. Neuroscience. 2021;doi: 10.1016/j.neuroscience.2021.10.016.
McDougle, S. D. (2021). Post-error Slowing During Instrumental Learning is Shaped by Working Memory-based Choice Strategies. Neuroscience, . https://doi.org/10.1016/j.neuroscience.2021.10.016
McDougle, Samuel D. "Post-error Slowing During Instrumental Learning is Shaped by Working Memory-based Choice Strategies." Neuroscience vol. (2021). doi: https://doi.org/10.1016/j.neuroscience.2021.10.016
McDougle SD. Post-error Slowing During Instrumental Learning is Shaped by Working Memory-based Choice Strategies. Neuroscience. 2021 Oct 23; doi: 10.1016/j.neuroscience.2021.10.016. Epub 2021 Oct 23. PMID: 34695537.
Copy Download .nbib Format: NLM
Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases.

Journal of developmental and behavioral pediatrics : JDBP

Howe YJ, Thom RP, Notson EE, McDougle CJ, Palumbo ML.
PMID: 33965971
J Dev Behav Pediatr. 2021 May 07; doi: 10.1097/DBP.0000000000000970. Epub 2021 May 07.

OBJECTIVE: Reports on the pharmacologic treatment of anxiety, including generalized anxiety disorder (GAD), in individuals with Down syndrome (DS) are lacking.METHODS: We present the case histories of 1 adolescent and 2 young adults with DS and the treatment course...

Cite
Howe YJ, Thom RP, Notson EE, et al. Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases. J Dev Behav Pediatr. 2021;doi: 10.1097/DBP.0000000000000970.
Howe, Y. J., Thom, R. P., Notson, E. E., McDougle, C. J., & Palumbo, M. L. (2021). Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases. Journal of developmental and behavioral pediatrics : JDBP, . https://doi.org/10.1097/DBP.0000000000000970
Howe, Yamini J, et al. "Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases." Journal of developmental and behavioral pediatrics : JDBP vol. (2021). doi: https://doi.org/10.1097/DBP.0000000000000970
Howe YJ, Thom RP, Notson EE, McDougle CJ, Palumbo ML. Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases. J Dev Behav Pediatr. 2021 May 07; doi: 10.1097/DBP.0000000000000970. Epub 2021 May 07. PMID: 33965971.
Copy Download .nbib Format: NLM
Workout Pacing Predictors of Crossfit.

Journal of human kinetics

Mangine GT, Feito Y, Tankersley JE, McDougle JM, Kliszczewicz BM.
PMID: 34025867
J Hum Kinet. 2021 Mar 31;78:89-100. doi: 10.2478/hukin-2021-0043. eCollection 2021 Mar.

To observe workout repetition and rest interval pacing strategies and determine which best predicted performance during the 2016 CrossFit® Open, five male (34.4 ± 3.8 years, 176 ± 5 cm, 80.3 ± 9.7 kg) and six female (35.2 ±...

Cite
Mangine GT, Feito Y, Tankersley JE, et al. Workout Pacing Predictors of Crossfit. J Hum Kinet. 2021;78:89-100doi: 10.2478/hukin-2021-0043.
Mangine, G. T., Feito, Y., Tankersley, J. E., McDougle, J. M., & Kliszczewicz, B. M. (2021). Workout Pacing Predictors of Crossfit. Journal of human kinetics, 7889-100. https://doi.org/10.2478/hukin-2021-0043
Mangine, Gerald T, et al. "Workout Pacing Predictors of Crossfit." Journal of human kinetics vol. 78 (2021): 89-100. doi: https://doi.org/10.2478/hukin-2021-0043
Mangine GT, Feito Y, Tankersley JE, McDougle JM, Kliszczewicz BM. Workout Pacing Predictors of Crossfit. J Hum Kinet. 2021 Mar 31;78:89-100. doi: 10.2478/hukin-2021-0043. eCollection 2021 Mar. PMID: 34025867; PMCID: PMC8120962.
Copy Download .nbib Format: NLM
Evaluation and Treatment of New-Onset Psychotic Symptoms in a Patient with Autism Spectrum Disorder and Multiple Autoimmune Disorders.

Harvard review of psychiatry

Macenski CL, Kimball A, Gansner M, Levy M, Megargel E, McDougle CJ, Thom RP.
PMID: 34524779
Harv Rev Psychiatry. 2021 Sep-Oct 01;29(5):378-387. doi: 10.1097/HRP.0000000000000314.

No abstract available.

Cite
Macenski CL, Kimball A, Gansner M, et al. Evaluation and Treatment of New-Onset Psychotic Symptoms in a Patient with Autism Spectrum Disorder and Multiple Autoimmune Disorders. Harv Rev Psychiatry. 2021;29(5):378-387doi: 10.1097/HRP.0000000000000314.
Macenski, C. L., Kimball, A., Gansner, M., Levy, M., Megargel, E., McDougle, C. J., & Thom, R. P. (2021). Evaluation and Treatment of New-Onset Psychotic Symptoms in a Patient with Autism Spectrum Disorder and Multiple Autoimmune Disorders. Harvard review of psychiatry, 29(5), 378-387. https://doi.org/10.1097/HRP.0000000000000314
Macenski, Christina L, et al. "Evaluation and Treatment of New-Onset Psychotic Symptoms in a Patient with Autism Spectrum Disorder and Multiple Autoimmune Disorders." Harvard review of psychiatry vol. 29,5 (2021): 378-387. doi: https://doi.org/10.1097/HRP.0000000000000314
Macenski CL, Kimball A, Gansner M, Levy M, Megargel E, McDougle CJ, Thom RP. Evaluation and Treatment of New-Onset Psychotic Symptoms in a Patient with Autism Spectrum Disorder and Multiple Autoimmune Disorders. Harv Rev Psychiatry. 2021 Sep-Oct 01;29(5):378-387. doi: 10.1097/HRP.0000000000000314. PMID: 34524779.
Copy Download .nbib Format: NLM
Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder.

Journal of autism and developmental disorders

Bradshaw J, Gillespie S, McCracken C, King BH, McCracken JT, Johnson CR, Lecavalier L, Smith T, Swiezy N, Bearss K, Sikich L, Donnelly C, Hollander E, McDougle CJ, Scahill L.
PMID: 33151499
J Autism Dev Disord. 2021 Sep;51(9):3039-3049. doi: 10.1007/s10803-020-04625-x.

Parents of children with autism spectrum disorder (ASD) face higher levels of caregiver strain compared to parents of children with other disabilities. This study examined child clinical features that predict high levels of caregiver strain for 374 parents of...

Cite
Bradshaw J, Gillespie S, McCracken C, et al. Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder. J Autism Dev Disord. 2021;51(9):3039-3049doi: 10.1007/s10803-020-04625-x.
Bradshaw, J., Gillespie, S., McCracken, C., King, B. H., McCracken, J. T., Johnson, C. R., Lecavalier, L., Smith, T., Swiezy, N., Bearss, K., Sikich, L., Donnelly, C., Hollander, E., McDougle, C. J., & Scahill, L. (2021). Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder. Journal of autism and developmental disorders, 51(9), 3039-3049. https://doi.org/10.1007/s10803-020-04625-x
Bradshaw, Jessica, et al. "Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder." Journal of autism and developmental disorders vol. 51,9 (2021): 3039-3049. doi: https://doi.org/10.1007/s10803-020-04625-x
Bradshaw J, Gillespie S, McCracken C, King BH, McCracken JT, Johnson CR, Lecavalier L, Smith T, Swiezy N, Bearss K, Sikich L, Donnelly C, Hollander E, McDougle CJ, Scahill L. Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder. J Autism Dev Disord. 2021 Sep;51(9):3039-3049. doi: 10.1007/s10803-020-04625-x. PMID: 33151499.
Copy Download .nbib Format: NLM
Challenges and Strategies to Mitigate Problematic Social Media Use in Psychiatric Disorders.

Harvard review of psychiatry

Macenski CL, Hamel MP, McDougle CJ, Thom RP.
PMID: 34366409
Harv Rev Psychiatry. 2021 Nov-Dec 01;29(6):409-415. doi: 10.1097/HRP.0000000000000308.

LEARNING OBJECTIVES: After participating in this activity, learners should be better able to:• Outline and discuss strategies to mitigate problematic social media use in psychiatric disorders• Identify solutions to encourage healthy use.ABSTRACT: Social media has been found to contribute...

Cite
Macenski CL, Hamel MP, McDougle CJ, et al. Challenges and Strategies to Mitigate Problematic Social Media Use in Psychiatric Disorders. Harv Rev Psychiatry. 2021;29(6):409-415doi: 10.1097/HRP.0000000000000308.
Macenski, C. L., Hamel, M. P., McDougle, C. J., & Thom, R. P. (2021). Challenges and Strategies to Mitigate Problematic Social Media Use in Psychiatric Disorders. Harvard review of psychiatry, 29(6), 409-415. https://doi.org/10.1097/HRP.0000000000000308
Macenski, Christina L, et al. "Challenges and Strategies to Mitigate Problematic Social Media Use in Psychiatric Disorders." Harvard review of psychiatry vol. 29,6 (2021): 409-415. doi: https://doi.org/10.1097/HRP.0000000000000308
Macenski CL, Hamel MP, McDougle CJ, Thom RP. Challenges and Strategies to Mitigate Problematic Social Media Use in Psychiatric Disorders. Harv Rev Psychiatry. 2021 Nov-Dec 01;29(6):409-415. doi: 10.1097/HRP.0000000000000308. PMID: 34366409.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 52 entries